Skip to main content
. 2016 Mar 30;2016:4152704. doi: 10.1155/2016/4152704

Table 1.

VAGs/characteristics among the CTX-M producers (n = 40) and nonproducers (n = 17).

VAGs/resistance Number (%) of strains positive for the VAG/characteristic
ESBL producers (n = 57) CTX-M
producers (n = 40)
Non-CTX-M
producers (n = 17)
p value
pap 19 (33.3) 16 (40) 3 (17.7) 0.1833
sfa/foc 1 (1.8) 0 (0) 1 (5.9) 0.6564
afa/dra 3 (5.3) 2 (5) 1 (5.9) 0.8914
iutA 32 (56.1) 24 (60) 8 (47.1) 0.5425
fyuA 45 (78.9) 32 (80) 13 (76.5) 0.7649
iroN 20 (35.1) 15 (37.5) 5 (29.4) 0.7779
kpsMII 21 (36.8) 18 (45) 3 (17.7) 0.0486a
usp 19 (33.3) 11 (27.5) 8 (47.1) 0.2602
Haemolysis 3 (5.3) 2 (5) 1 (5.9) 0.8914
AmpC 54 (94.7) 40 (100) 14 (82.4) 0.0374b
CIPR 47 (82.5) 37 (92.5) 10 (58.8) 0.0037c
SXTR 57 (100) 40 (100) 17 (100) 1
GENR 38 (66.7) 30 (75) 8 (47.1) 0.0818
CIPRSXTRGENR 35 (61.4) 28 (70) 7 (41.2) 0.0403d

VAGs: virulence associated genes, CIPR: resistant to CIP, SXTR: resistant to SXT, GENR: resistant to GEN, and CIPRSXTRGENR: multidrug resistance.

a p < 0.05, odds ratio: 3.8182, and 95% CI: 0.9473 to 15.389.

b p < 0.05, odds ratio: 32.3665, and 95% CI: 2.607 to 401.8328.

c p < 0.05, odds ratio: 8.6333, and 95% CI: 1.8839 to 39.5634.

d p < 0.05, odds ratio: 3.3333, and 95% CI: 1.0252 to 10.8382.